trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Humans develop immunity to SARS-CoV-2

the verdict
SUPPORTED
the evidence backs this
Recorded sources
7 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that humans develop immunity to SARS-CoV-2?

Yes. Extensive immunological research confirms that humans develop durable adaptive immunity to SARS-CoV-2, characterized by long-lasting memory T cells, memory B cells, and persistent antibody responses following infection or vaccination.

Verdict: SUPPORTED · 7 sources for, 0 against · Last checked

The analysis

The claim that humans develop immunity to SARS-CoV-2 is overwhelmingly supported by multiple peer-reviewed studies documenting the generation of durable T-cell memory, memory B-cells, and long-term neutralizing antibody responses after infection and vaccination.

Evidence for · 7
2020
Longitudinal tracking shows that mild COVID-19 infection induces persistent SARS-CoV-2-responding CD4+ and CD8+ T cell clones with memory phenotypes.
Get citation
Minervina, A., Komech, E., Titov, A., Koraichi, M. B., Rosati, E., Mamedov, I., Franke, A., Efimov, G., Chudakov, D., Mora, T., Walczak, A., Lebedev, Y., & Pogorelyy, M. (2020). Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T-cell memory formation after mild COVID-19 infection. doi.org. https://doi.org/10.7554/eLife.63502

See more details
More for · 6
2021
Antibody studies demonstrate that neutralizing antibody responses can persist for long periods following infection, providing sustained protection.
Get citation
Lau, E., Hui, D., Tsang, O., Chan, W., Kwan, M., Chiu, S., Cheng, S. M. S., Ko, R., Li, J. K. C., Chaothai, S., Tsang, C., Poon, L., & Peiris, M. (2021). Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection. doi.org. https://doi.org/10.1016/j.eclinm.2021.101174

2021
Convalescent plasma donor data indicate long-term persistence of spike antibodies, establishing humoral immune memory despite some waning of neutralization ability.
Get citation
Terpos, E., Stellas, D., Rosati, M., Sergentanis, T., Hu, X., Politou, M., Pappa, V., Ntanasis-Stathopoulos, I., Karaliota, S., Bear, J., Donohue, D., Pagoni, M., Grouzi, E., Korompoki, E., Pavlakis, G., Felber, B., & Dimopoulos, M. (2021). SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors. doi.org. https://doi.org/10.1016/j.ejim.2021.05.010

2023
Research confirms that T cell memory after COVID-19 infection or vaccination is broad, durable, and provides lasting resistance.
Get citation
Wang, L., Nicols, A., Turtle, L., Richter, A., Duncan, C., Dunachie, S., Klenerman, P., & Payne, R. (2023). T cell immune memory after covid-19 and vaccination. doi.org. https://doi.org/10.1136/bmjmed-2022-000468

2024
Studies of post-pandemic immune memory reveal durable, broadly targeted, and cross-reactive CD4+ and CD8+ spike-specific T-cell responses.
Get citation
Nesamari, R., Omondi, M. A., Baguma, R., Höft, M. A., Ngomti, A., Nkayi, A. A., Besethi, A. S., Magugu, S. F., Mosala, P., Walters, A., Clark, G. M., Mennen, M., Skelem, S., Adriaanse, M., Grifoni, A., Sette, A., Keeton, R. S., Ntusi, N., Riou, C., & Burgers, W. (2024). Post-pandemic memory T-cell response to SARS-CoV-2 is durable, broadly targeted and cross-reactive to hypermutated BA.2.86. doi.org. https://doi.org/10.1016/j.chom.2023.12.003

2021
Analysis of convalescent patients shows the persistence of humoral immunity alongside the establishment of classical and activated memory B-cell subsets.
Get citation
Rajamanickam, A., Kumar, N. P., P, A. N., Selvaraj, N., Munisankar, S., Renji, R. M., V, V., Murhekar, M., Thangaraj, J., Kumar, M., Kumar, C., Bhatnagar, T., Ponnaiah, M., Sabarinathan, R., Kumar, V., & Babu, S. (2021). Recovery of Memory B-cell Subsets and Persistence of Antibodies in Convalescent COVID-19 Patients. doi.org. https://doi.org/10.4269/ajtmh.21-0883

2025
Cohort data document durable anti-spike IgG and neutralizing antibody responses generated by natural infection and hybrid immunity.
Get citation
Nouanesengsy, A., Semesi, A., Quach, K., Ivanochko, D., Byrne, W., Hwang, M., Neve, M. L., Leon-Ponte, M., Litosh, A., Wisener, N., Adeli, K., Campigotto, A., Grunebaum, E., McGeer, A., Moraes, T. J., Sepiashvili, L., Upton, J., Julien, J., & Allen, U. D. (2025). Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort. doi.org. https://doi.org/10.1128/spectrum.01333-24

Related receipts

What does the evidence say?

The claim that humans develop immunity to SARS-CoV-2 is overwhelmingly supported by multiple peer-reviewed studies documenting the generation of durable T-cell memory, memory B-cells, and long-term neutralizing antibody responses after infection and vaccination.

Receipt History
first checked04 Aug 2026
judged → SUPPORTED · 8804 Aug 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work